Form 4: Dolby Laboratories CEO Kevin Yeaman Executes Stock Option and Sells Shares

Dolby Laboratories CEO Kevin Yeaman exercised stock options and sold shares of Class A Common Stock on October 15, 2024, according to a recent SEC filing.

Summary

• On October 15, 2024, Kevin Yeaman, the President and CEO of Dolby Laboratories, exercised a stock option to acquire 28,512 shares of Class A Common Stock at a price of $62.32 per share.
• Concurrently, Yeaman sold 18,696 shares at a weighted average price of $73.8999 and 9,816 shares at a weighted average price of $74.5467.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
• Following these transactions, Yeaman directly owns 120,320 shares and indirectly owns 83,721 shares through the Kevin and Rachel Yeaman Family Trust dated May 14, 2009.
• The filing also corrects a previously reported amount of shares held by the trust, adjusting it from 83,271 to 83,721 as of June 25, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors. These transactions can provide insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of the company's CEO.
• The transactions have no immediate impact on employees, customers, suppliers, or creditors.

Key Dates